chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Palpitations, Tachycardia, "Woozy", Lips itchy/dry Narrative:  Noted patient checking her carotid pulse with her right hand as new band-aid being applied. Asked patient what was happening or wrong. Stated she felt her heart racing with palpitations. Requested assistance with vital sign monitoring. 15:18 Pulse 99 O2 sat 99% . States she continues to have tachycardia and palpitations and a bit "woozy". 15:19 Pulse 115, 99% O2 sat, BP 149/90 in right arm. States continues to have palpations and now a pain level of 4 in left lower anterior chest wall and lips are now itchy and dry. 50mg Benadryl given PO with water. 15:20 O2 sat 99% BP 142/87 pulse 89. States lips continue to be dry but less itchy and decrease in Left lower anterior chest wall pain. 15:25 O2 sat 99%, Pulse 86, BP 132/84. States lips continue to be dry no longer itchy, no further heart palpitations and decrease in Left lower anterior chest wall pain level 2 or 3 now 1530 O2 sat 100% Pulse 78. Alert oriented states feeling better. 1535 O2 sat 99% P 74 BP 111/69. States no further issues with lips. Chest wall pain now a level 1. 1545 O2 sat 99% P 74 BP 117/75. No further chest wall pain. All issues resolved. 1600 O2 sat 99%, P 73, BP 119/76. No pain. Patient stood, bent over, walked around no issues states feel normal with no issues.
01/25/22 presents to Birth Center Triage for "elevated BP". PMHx of "Anxiety disorder, Bipolar disorder"
12/7/21   69-year-old diabetic male who has been fully vaccinated against COVID-19 presents with a 3-day history of head congestion, headaches, body aches, chills.  No fever at home.  Denies pre-existing lung disease.  No shortness of breath.  He has taken Aleve for symptoms.  No known COVID-19 exposures
Pt received first moderna as a underage minor. Parent with pt here for second dose parent stated pt did not have any adverse reaction with the first dose. PharmD aware and spoke to pt and parent on efficacy and aware moderna is not yet authorized for underage.  Parent still requested second dose and consent signed as witnessed by pharmD
The case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a patient who received FLUARIX QUADRIVALENT (batch number 77R93, expiry date 30th June 2018) and (batch number 34RE5, expiry date 30th June 2018). On an unknown date, the patient received FLUARIX QUADRIVALENT. On an unknown date, the dose was an unknown dose. On an unknown date, 5 min after receiving FLUARIX QUADRIVALENT, the patient experienced injection site pain, injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site pain, injection site swelling and injection site erythema were not recovered/not resolved. The reporter considered the injection site pain, injection site swelling and injection site erythema to be almost certainly related to FLUARIX QUADRIVALENT. Additional details were provided as follows: This case was reported by Medical Assistant. The health care professional reported the patient had injection site reactions after receiving FLUARIX. The symptoms reported included pain, swelling, and redness the size of a half dollar. No patient information was available. This was 1 of 4 cases as reported by same reporter for same events.
Redness at the injection site; body aches; nausea; This is a spontaneous report from a contactable consumer (who is the patient, self reported).  This 43-Years-old (not pregnant) female patient received second dose of BNT162B2 (Solution for injection, lot number: EL3247 expiry date: unknown) via an unspecified route of administration in Left arm on 11Feb2021 at 14:30, as single dose for Covid-19 immunization. The patient had no Known allergies. The patient did not receive other vaccine in four weeks, was not having COVID prior vaccination. Concomitant medications were not reported. Patient had earlier received first dose of BNT162B2 (Solution for injection, lot number: EL3247 expiry date: unknown) via an unspecified route of administration in Left arm on 21Jan2021 14:30 PM, as single dose for Covid-19 immunization.  On 12Feb2021 at 04:00, (post second dose) the patient experienced redness at the injection site, body aches and nausea. Patient did not receive any treatment for the adverse events. Patient was not tested for COVID post vaccination. Events, Redness at the injection site, body aches and nausea were non-serious. Outcome of the events was reported as recovering.   No other information was available.     No other information was available.
Chest pains, shortness of breath, vomiting, passing out twice with in the first few hours of the vaccine.
Twenty to thirty minutes past injection of PREVNAR, MMR, Varicella, and Hep A child has red bumps on chest, back, stomach, and chin. Axillary temp 95.3.
Swelling of LD, nausea, lightheadedness, and lasted x 2 days.
Patient administered 1st dose of Moderna vaccine by certified immunizing pharmacy tech. Patient exhibiting signs of anxiety. She reported symptoms of chest tightness, feeling tingling and possible hives (not visual) down arms, headache, tightness behind neck, and some difficulty breathing within 5 minutes after administration.
Patient passed out immediately following receiving the vaccine and then she had 2 30 second generalized seizure.
received 3rd dose of Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 06th January 2023) and Shingrix (2nd dose received on 08th April 2023).   On 10-JUL-2023, the patient received the 3rd dose of Shingrix. On 10-JUL-2023, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: received 3rd dose of Shingrix). The outcome of the extra dose administered was unknown.   Additional Information: GSK receipt date: 10-JUL-2023 The pharmacist stated that a patient went to the pharmacy to receive a second dose of Shingrix after receiving first dose on 06th January 2023. Vaccination was completed on 10th July 2023. When pharmacist submitted information to the insure found that patient in fact received the second dose of Shingrix on 08th April 2023 in a different pharmacy.  Pharmacist contacted to confirm that.  Patient stated that she did not recall getting that second dose, resulting in getting an extra dose of Shingrix which led to extra dose administered. According to pharmacist the patient is doing fine, no side effects reported.  The reporter consented to follow up.
Patient called 12/5/13 and said that when she left she went shopping at 2 other stores and during that time she had weakness in her leg and her arm then had shallow breathing. She stated she did not go to be seen and went home and rested.
bladder infection; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unknown date as a single dose for COVID-19 vaccination. Medical history included cancer from an unknown date. Concomitant medications were not reported. The patient experienced a bladder infection on an unknown date reported as she developed a bladder infection and is "pretty sure I had it before and is not from the Covid shot." The patient underwent a physical in which they took blood work with no results reported and a urine test which revealed a bladder infection, both on an unknown date. Therapeutic measures were taken as a result of the bladder infection which included Bactrim/Septra which was started "yesterday", taken two times a day for three days. The patient is scheduled for the second dose of BNT162B2 the morning after the last dose of Bactrim/Septra. The outcome of the event bladder infection was unknown.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
administered infanrix  instead of boostrix; 72 Y / administered infanrix; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 72-year-old male patient who received DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st November 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 1st November 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The 72 year old patient was administered the infanrix vaccine instead of the boostrix vaccine, which led to wrong vaccine administered and inappropriate age at vaccine administration. She stated she had not yet spoken to the patient. The reporter consented to follow up.
SLURRED SPEECH; TINGLING FEELING IN ALL FOUR LIMBS; STROKE; VISION DECREASED; This spontaneous report received from a patient via the VAERS (Vaccine Adverse Event Reporting System;)  a 57 year old male. The patient's height, and weight were not reported. The patient's past medical history included history of CABG (Coronary artery bypass grafting), and concurrent conditions included diabetes mellitus, congestive heart failure, and diabetic retinopathy, and other pre-existing medical conditions included the patient had no known allergies to medications, food, or other products and did not had other illnesses at the time of vaccination and up to one month prior. The patient did not have an adverse event following any previous vaccination. The patient, at age of 57 years, received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 to left arm for prophylactic vaccination. Concomitant medications included insulin and insulin lispro for drug used for unknown indication.  On 20-APR-2021, the patient began experiencing tingling feeling in all four limbs at different times. On 28-MAR-2021, patient experienced slurred speech. The patient experienced what he described as near blindness. The patient was driving down road and all of the sudden most of visual field went black and could only see the white lines of the road. The patient was close to hospital and was able to see enough to get himself to the hospital and was diagnosed as having a stroke. The patient had CT, MRI, and ultrasound of heart (results unspecified).  The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tingling feeling in all four limbs, slurred speech, vision decreased and stroke was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: 20210440193-covid-19 vaccine ad26.cov2.s-Stroke, Vision decreased, Tingling sensation in all four limbs, Slurred speech. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY: history of CABG, UNDERLYING DISEASE: congestive heart failure, and diabetic retinopathy
The night I received the shot I had a headache, muscle aches, chill, fever 100.3. I went to bed bundled in clothes to get warm but could not sleep. The pain in my muscles made it impossible to relax. I finally called the Hot Line at 12:47am. I asked them if I could take some Tylenol. They said that my reactions were normal and I should tough it out. The vaccine was doing it's. i continued to suffer all night. I alternately placed a heating pad on my legs, lower back and neck. This gave me some relief but no sleep. At 8am my doctor returned my call and said it was OK to take Tylenol and that I could have taken it last. She said that it was not recommended to take any Tylenol before receiving the shot. Darn. I slept all day 02/19. This morning I noticed that I had a rash and lump below the injection site it is warm to the touch but not itchy.
Pain and swelling in his armpit; Neck was stiff; Can't touch his armpit because it is tender/very tender; Pain and swelling in his armpit; Tired; Not feeling his best; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Pain and swelling in his armpit), MUSCULOSKELETAL STIFFNESS (Neck was stiff), MALAISE (Not feeling his best), TENDERNESS (Can't touch his armpit because it is tender/very tender) and AXILLARY PAIN (Pain and swelling in his armpit) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A, 029K20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Dec-2021 at 4:30 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Dec-2021, the patient experienced MALAISE (Not feeling his best) and FATIGUE (Tired). On 07-Dec-2021, the patient experienced SWELLING (Pain and swelling in his armpit), MUSCULOSKELETAL STIFFNESS (Neck was stiff), TENDERNESS (Can't touch his armpit because it is tender/very tender) and AXILLARY PAIN (Pain and swelling in his armpit). The patient was treated with IBUPROFEN for Pain and Swelling, at an unspecified dose and frequency. At the time of the report, SWELLING (Pain and swelling in his armpit) had not resolved and MUSCULOSKELETAL STIFFNESS (Neck was stiff), MALAISE (Not feeling his best), TENDERNESS (Can't touch his armpit because it is tender/very tender), AXILLARY PAIN (Pain and swelling in his armpit) and FATIGUE (Tired) outcome was unknown.            No Concomitant medication was reported.     Treatment medications included cold towel.  Patient also had something towards the groin area but does not attribute that to the vaccine.
1/5/2021 1st covid vaccine Pfizer EL0140 2p Left arm 1/26/2021 2nd covid vaccine Pfizer EJ1686 2p Left arm 3/25/2021 work place exposure 4/4/2021 ill 4/5/2021 Covid positive test with PCR
Symptoms of laryngitis within 24 hours progressed to near full voice loss in 4 days.
Hives developed in clusters on trunk on 09/22/05 and lasted until 09/23/05. Child also ran a low grade temp for 2 days.
Myalgia, Arthralgia, Fever & NauseaVomiting Narrative:  dose 2-day 1-2-tender/warm inj site; day 1-3-fever; chills; n/v; muscle and joint pain; fatigue  Other Relevant History:
AM of 5/7/14 pt. noticed 3 inch by 2 inch area of swelling around injection site. It was itchy and hot to the touch. It was also painful. Ice was used and provided some relief.
nausea again; her eyes were sensitive to the light; they don't feel right; it was the worst day; a very bad nausea; splitting headache; backache; muscle ache; didn't have any appetite; she began with symptoms; This spontaneous case was reported by a consumer and describes the occurrence of SYMPTOM RECURRENCE (she began with symptoms), FEELING ABNORMAL (it was the worst day), NAUSEA (a very bad nausea), HEADACHE (splitting headache) and BACK PAIN (backache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Polymyalgia rheumatica and Sjogren's. Concomitant products included HYDROXYCHLOROQUINE, VALSARTAN, HYDROCHLOROTHIAZIDE and FAMOTIDINE for an unknown indication.  On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced SYMPTOM RECURRENCE (she began with symptoms). On 20-Feb-2021, the patient experienced FEELING ABNORMAL (it was the worst day), NAUSEA (a very bad nausea), HEADACHE (splitting headache), BACK PAIN (backache), MYALGIA (muscle ache) and DECREASED APPETITE (didn't have any appetite). On 23-Feb-2021, the patient experienced NAUSEA (nausea again), PHOTOPHOBIA (her eyes were sensitive to the light) and MALAISE (they don't feel right). At the time of the report, SYMPTOM RECURRENCE (she began with symptoms), NAUSEA (a very bad nausea), HEADACHE (splitting headache), BACK PAIN (backache), MYALGIA (muscle ache), DECREASED APPETITE (didn't have any appetite), NAUSEA (nausea again), PHOTOPHOBIA (her eyes were sensitive to the light) and MALAISE (they don't feel right) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Excedrin: Aspirin/Paracetamol/Caffeine.
Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: pt states her arm swelled from the elbow to her shoulder on her left side lasted about 6 days
rash: diffuse erythroderma blisters upper arms, inner thighs superficial desquamation face, chest;resolved w/med;
None, due to refrigerator temperature excursion on 8/12/2016, manufacture determined based on drop in temperature that the vaccine is not viable and CDC recommended revaccination.
Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. It was reported tat the patient took half dose booster. Vial was initially stored in the refrigerator on 31-Jan-2022. It was reported that the vial did not undergo any temperature excursions. Treatment information was not provided.   This case was linked to MOD-2022-525860 (Patient Link).
Patient tested positive for covid 7/24/21 began with symptoms 7/23/21 was symptomatic for about 10 days lost smell. she also had covid in December 2020 before vaccine
PATIENT WAS ADMINISTERED THE VACCINE THAT WAS 5 DAYS PAST THE BEYOND USE DATE.  THE PRODUCT WAS REFRIDGERATED FOR A 35 DAY PERIOD.
1 vaccine 4 days later i ended up in the ER; chills beyond my control, feeling of dying, could not breathe, anxiety,  shaking so bad i could not control it for days i was sick, really back at the ER blood work was done showed i had thyroid 4 days later went to my PCP doctor more blood work done at my results i had no thyroid issues days later. 2nd vaccine was even worse,  went to the ER on the 3rd day, left side of my neck was stiff, left ear ache, left side of my  head pounding, cold, shaking was horrible, nauseous, pain and numbness on my legs, my PCP said the vaccine is on overdrive in my body 9 days later and i'm overcoming it it was the  worse experiences of my life
Swollen cervical/neck lymph node glands - left & right (Has not yet subsided) Stiffness, achiness in neck & upper back Fever, chills, body aches, dizziness, nausea Soreness & itchiness & lump/swelling at vaccine sight - left arm
Patient had Erythema, pruritis and urticaria spread over body. Treated with steroid injection and steroid dose pack starting 12/5/2022
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 10-DEC-2018, the patient was vaccinated with improperly stored VAQTA (lot # R013859, expiration date 14-JUN-2019) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
Information has been received from a physician concerning a 10 month old female with a history of wheezing who was vaccinated with 3 doses of RECOMBIVAX HB on unspecified date. There was no concomitant medication. In December 2006, the patient experienced seizure followed by a cerebral vascular accident. The patient was hospitalized on unspecified date. The patient initially had speech and motor delays but the reporter added "she is doing well now". On unknown date, the patient recovered. Seizure, initially had speech and motor delays and a cerebral vascular accident were reported as immediately life-threatening and disabling. Additional information has been requested.
Day of injection, started feeling like I was light headed and high, could not concentrate. The next three days, muscles in back of neck and shoulders tightened, hard to lift arms, tired and headache on left side, coughing and hot flashes started on Friday to Sunday with insomnia and diarrhea, saw doctor on Monday . As of today, headache on left side of temple and muscle soreness